These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 28057300)

  • 1. Neurotoxicity Pathways in Drosophila Models of the Polyglutamine Disorders.
    Krench M; Littleton JT
    Curr Top Dev Biol; 2017; 121():201-223. PubMed ID: 28057300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of pathways controlling toxicity in the eye and brain in Drosophila models of human neurodegenerative diseases.
    Ghosh S; Feany MB
    Hum Mol Genet; 2004 Sep; 13(18):2011-8. PubMed ID: 15254017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathogenic agent in Drosophila models of 'polyglutamine' diseases.
    McLeod CJ; O'Keefe LV; Richards RI
    Hum Mol Genet; 2005 Apr; 14(8):1041-8. PubMed ID: 15757976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studying polyglutamine diseases in Drosophila.
    Xu Z; Tito AJ; Rui YN; Zhang S
    Exp Neurol; 2015 Dec; 274(Pt A):25-41. PubMed ID: 26257024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal transport in a Drosophila model of Huntington's disease.
    Lee WC; Yoshihara M; Littleton JT
    Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3224-9. PubMed ID: 14978262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AQAMAN, a bisamidine-based inhibitor of toxic protein inclusions in neurons, ameliorates cytotoxicity in polyglutamine disease models.
    Hong H; Koon AC; Chen ZS; Wei Y; An Y; Li W; Lau MHY; Lau KF; Ngo JCK; Wong CH; Au-Yeung HY; Zimmerman SC; Chan HYE
    J Biol Chem; 2019 Feb; 294(8):2757-2770. PubMed ID: 30593503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autophagy and polyglutamine diseases.
    Jimenez-Sanchez M; Thomson F; Zavodszky E; Rubinsztein DC
    Prog Neurobiol; 2012 May; 97(2):67-82. PubMed ID: 21930185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of cell death in polyglutamine expansion diseases.
    Lipinski MM; Yuan J
    Curr Opin Pharmacol; 2004 Feb; 4(1):85-90. PubMed ID: 15018844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential therapeutic targets in polyglutamine-mediated diseases.
    Katsuno M; Watanabe H; Yamamoto M; Sobue G
    Expert Rev Neurother; 2014 Oct; 14(10):1215-28. PubMed ID: 25190502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of polyglutamine oligomerization and neurodegeneration by the peptide inhibitor QBP1 in Drosophila.
    Nagai Y; Fujikake N; Ohno K; Higashiyama H; Popiel HA; Rahadian J; Yamaguchi M; Strittmatter WJ; Burke JR; Toda T
    Hum Mol Genet; 2003 Jun; 12(11):1253-9. PubMed ID: 12761040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glial and neuronal expression of polyglutamine proteins induce behavioral changes and aggregate formation in Drosophila.
    Kretzschmar D; Tschäpe J; Bettencourt Da Cruz A; Asan E; Poeck B; Strauss R; Pflugfelder GO
    Glia; 2005 Jan; 49(1):59-72. PubMed ID: 15390099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-stranded RNA is pathogenic in Drosophila models of expanded repeat neurodegenerative diseases.
    Lawlor KT; O'Keefe LV; Samaraweera SE; van Eyk CL; McLeod CJ; Maloney CA; Dang TH; Suter CM; Richards RI
    Hum Mol Genet; 2011 Oct; 20(19):3757-68. PubMed ID: 21724553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autophagy in polyglutamine disease: Imposing order on disorder or contributing to the chaos?
    Cortes CJ; La Spada AR
    Mol Cell Neurosci; 2015 May; 66(Pt A):53-61. PubMed ID: 25771431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila.
    Steffan JS; Bodai L; Pallos J; Poelman M; McCampbell A; Apostol BL; Kazantsev A; Schmidt E; Zhu YZ; Greenwald M; Kurokawa R; Housman DE; Jackson GR; Marsh JL; Thompson LM
    Nature; 2001 Oct; 413(6857):739-43. PubMed ID: 11607033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p62 plays a protective role in the autophagic degradation of polyglutamine protein oligomers in polyglutamine disease model flies.
    Saitoh Y; Fujikake N; Okamoto Y; Popiel HA; Hatanaka Y; Ueyama M; Suzuki M; Gaumer S; Murata M; Wada K; Nagai Y
    J Biol Chem; 2015 Jan; 290(3):1442-53. PubMed ID: 25480790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human neurodegenerative disease modeling using Drosophila.
    Bonini NM; Fortini ME
    Annu Rev Neurosci; 2003; 26():627-56. PubMed ID: 12704223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azadiradione ameliorates polyglutamine expansion disease in Drosophila by potentiating DNA binding activity of heat shock factor 1.
    Nelson VK; Ali A; Dutta N; Ghosh S; Jana M; Ganguli A; Komarov A; Paul S; Dwivedi V; Chatterjee S; Jana NR; Lakhotia SC; Chakrabarti G; Misra AK; Mandal SC; Pal M
    Oncotarget; 2016 Nov; 7(48):78281-78296. PubMed ID: 27835876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of behaviors and segmental coordination during larval locomotion is disrupted by nuclear polyglutamine inclusions in a new Drosophila Huntington's disease-like model.
    Nishimura Y; Yalgin C; Akimoto S; Doumanis J; Sasajima R; Nukina N; Miyakawa H; Moore AW; Morimoto T
    J Neurogenet; 2010 Dec; 24(4):194-206. PubMed ID: 21087194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurodegeneration by polyglutamine Atrophin is not rescued by induction of autophagy.
    Nisoli I; Chauvin JP; Napoletano F; Calamita P; Zanin V; Fanto M; Charroux B
    Cell Death Differ; 2010 Oct; 17(10):1577-87. PubMed ID: 20339376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular degradation of misfolded proteins in polyglutamine neurodegenerative diseases.
    Li X; Li H; Li XJ
    Brain Res Rev; 2008 Nov; 59(1):245-52. PubMed ID: 18773920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.